TSS
SRNE

Two Sigma Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Two Sigma Securities’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-43,868
Closed -$38.9K – 3489
2022
Q4 		$38.9K Buy
43,868
+3,052
+7% +$4.05K ﹤0.01% 2197
2022
Q3 		$64K Hold
40,816
– – ﹤0.01% 2158
2022
Q2 		$82K Buy
+40,816
New +$70.6K ﹤0.01% 1783
2020
Q2 		– Sell
-16,709
Closed -$31K – 1846
2020
Q1 		$31K Buy
+16,709
New +$48.1K ﹤0.01% 1212

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Two Sigma Securities's SRNE Position: Q1 2023 in Review

Two Sigma Securities sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 43,868 shares — an estimated $38.9K sold.

Two Sigma Securities first reported a position in SRNE in Q1 2020 and held it in 4 quarters. The position peaked at $82K in Q2 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Two Sigma Securities reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 43,868 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $38.9K.
  • Two Sigma Securities first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 4 quarters.
  • Two Sigma Securities's Sorrento Therapeutics, Inc. position peaked at $82K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.